MARKET INTRODUCTION
Feline Atopic Dermitis, also known as "Atopy" is an environmental allergy of the skin. It is a pruritic disease in which affected cats have a hypersensitivity reaction to inhaled or contacted environmental allergens. The age of onset is variable but generally is <5 yr.
MARKET DYNAMICS
Rising prevalence of feline atopic dermatitis is the major factor driving the market. For instance, as per Canadian Veterinary Journal it was reported that prevalence of feline atopy was reported to be 12.5%. Moreover, increasing trend of companion animal in the developing economies is further going to spur the market growth.
MARKET SCOPE
The "Global Feline Atopic Dermatitis Drug Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Feline Atopic Dermatitis Drug Market with detailed market segmentation by drug class, route of administration, distribution channel and geography. The Global Feline Atopic Dermatitis Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Feline Atopic Dermatitis Drug Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Feline Atopic Dermatitis Drug Market is segmented on the basis of drug class, route of administration and distribution channel. On the basis of drug class, market can be classified as corticosteroids, antihistamines and antibiotics. Based on route of administration the market is segmented into oral, topical and injectable. Based on distribution channel the market is segmented into veterinary pharmacies, hospital pharmacies and retail pharmacies.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Feline Atopic Dermatitis Drug Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Feline Atopic Dermatitis Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Feline Atopic Dermatitis Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Feline Atopic Dermatitis Drug Market in these regions.

MARKET PLAYERS
The report covers key developments in the Feline Atopic Dermatitis Drug Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Feline Atopic Dermatitis Drug Market are anticipated to lucrative growth opportunities in the future with the rising demand for Feline Atopic Dermatitis Drug Market in the global market. Below mentioned is the list of few companies engaged in the Feline Atopic Dermatitis Drug Market.
The report also includes the profiles of key Feline Atopic Dermatitis Drug Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bausch Health Companies
- Bayer
- Pfizer
- Novartis
- Sanofi
- Eli Lily
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Elanco
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.